Mentor Capital Partners

AGI Biopharmaceuticals, Ltd., a European firm that has developed a patented, economic, melanoma vaccine with future multi-cancer application.

Hadron Systems, Inc. is a NJ-based biotechnology company focused on developing the techniques and devices to support slow neutron therapy for cancers, including the targeting and ablation of tumor stroma cells, without which tumors cannot form.

Quantum Immunologics, Inc., a biotechnology company, engages in the research, development, and production of immunologic treatment systems for breast cancer. Its products include individualized cancer immunotherapy system, a system in which blood drawn from a patient is treated with a process and cells are injected back into the patient; cancer monitoring test that uses cancer immunotherapy to monitor blood levels of the immune response in a patient following treatment; and cancer screening test, a blood test. The company is based in Tampa, Florida.

Conformia Software, formerly known as RIVA Commerce, specializes in Product and Process Lifecycle Management Solutions tailored for the pharmaceutical and life sciences sectors, as well as other process manufacturing organizations. The company focuses on enhancing business productivity, visibility, and compliance throughout the product development lifecycle. Conformia's application software modules facilitate effective management of product and process definitions, scientific knowledge, and operational design, thereby supporting organizations in their product and process development endeavors. With a commitment to advancing the ICH vision, Conformia Software plays a pivotal role in stewarding essential lifecycle knowledge for the pharmaceutical industry in the 21st century.

Ascentive develops user-friendly software solutions for consumers and businesses, focusing on PC optimization and maintenance. With a portfolio of over a dozen products, the company is renowned for its innovative approach, backed by exceptional customer support. Ascentive's work has been recognized by prominent media outlets such as The Wall Street Journal and Forbes.